[1]Liu DQ, Li XJ, Weng XJ. Effect of BTXA on inhibiting hypertrophic scar formation in a rabbit ear model[J]. Aesthetic Plas Surg, 2017, 41:1-8. [2]Tang ZM, Zhai XX, Ding JC. Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention[J]. Mol Med Rep, 2017, 15:2546-2550. [3]Collesi C, Felician G, Secco I, et al. Reversible Notch1 acetylation tunes proliferative signaling in cardiomyocytes[J]. Cardiovasc Res, 2018, 114:103-122. [4]Zhang HD, Jiang LH, Sun DW, et al. miR-30a inhibits the biological function of breast cancer cells by targeting Notch1[J]. Int J Mol Med, 2017, 40:1235-1242. [5]Hrstka SC, Li X, Nelson TJ. NOTCH1-dependent nitric oxide signaling deficiency in hypoplastic left heart syndrome revealed through patient-specific phenotypes detected in bioengineered cardiogenesis[J]. Stem Cells, 2017, 35:1106-1119. [6]Hsu YH, Lin YF, Chen CH, et al. Far infrared promotes wound healing through activation of Notch1 signaling[J]. J Mol Med, 2017, 95:1-11. [7]Park JC, Chang IB, Ahn JH, et al. Nerve growth factor stimulates glioblastoma proliferation through notch1 receptor signaling[J]. J orean Neurosurg Soc, 2018, 61:441-449. [8]Tang ZM, Zhai XX, Ding JC. Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention[J]. Mol Med Rep, 2017, 15:2546-2550. [9]Blain SW. Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells[J]. Oncoscience, 2018, 5:144-145. [10]Pierozan P, Karlsson O. PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells[J]. Arch Toxicol, 2018, 92:705-716. [11]Gang D, Zheng X, Jiang P, et al. Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathway[J]. Oncol Lett, 2017, 14:4477-4482. [12]Lu CJ, He YF, Yuan WZ, et al. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells[J]. World J Gastroenterol, 2017, 23:6242-6251. [13]Liu T, Wu X, Li Y, et al. RBFOX3 regulates the chemosensitivity of cancer cells to 5-fluorouracil via the pi3k/akt, emt and cytochrome-c/caspase pathways[J]. Cell Physiol Biochem, 2018, 46:1365-1380. [14]Jiang S, Wang Q, Feng M, et al. C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells[J]. Appl Microbiol Biotechnol, 2017, 101:1535-1546. [15]Cheng J, Wu Q, Lv R, et al. MicroRNA-449a inhibition protects h9c2 cells against hypoxia/reoxygenation-induced injury by targeting the notch-1 signaling pathway[J]. Cell Physiol Biochem, 2018, 46:2587-2600. |